TissueGUARD

TissueGUARD is a spin-off project of the Leibniz Institute of Polymer Research Dresden (IPF) Germany www.ipfdd.de

TissueGUARD is an FDA-registered medical device company specializing in proprietary ophthalmic devices and accessories for Keratoplasty. The company also develops and offers advanced device engineering, hydrogel materials, and biotechnology solutions for tissue engineering, cell therapies, and organoid therapeutics.

08/03/2025

International Women’s Day! We wish all women worldwide a successful and fulfilling journey. At TissueGUARD, we especially celebrate the incredible women driving innovation in medicine, medical technology, and patient care.

06/02/2025

TissueGUARD is proud to exhibit at the 2025 Pittsburgh Cornea Symposium hosted by the Center for Organ Recovery & Education CORE! Join us at our booth to explore our solutions for DMEK and DSAEK applications. Don’t miss the chance to see our innovative devices and connect with our team. We look forward to seeing you there!

Not registered yet? Secure your spot here: https://core.org/professionals/eye-bank/2025-pittsburgh-cornea-symposium/

18/11/2024

During our visit to Philadelphia, we had a great opportunity to visit AltruVision. We presented our TissueGUARD devices for Keratoplasty and shared insights on their benefits for corneal transplantation. It was inspiring to see AltruVision's dedication to advancing eye banking and patient care. Thank you to Gregory Dorn for hosting us at the eye bank and giving us a tour of the facilities. Looking forward to future collaborations!

06/11/2024

We’re excited to exhibit once again at the Advanced Therapies USA conference, this time in Philadelphia!
Beyond our work in innovative medical devices for ophthalmology, TissueGUARD is developing advanced substitution therapies for diseases affecting the cornea, retina, and ischemia. Visit us at Stand 9 in the Startup Zone on November 12-13 to discover our technologies for tissue formation, organoid development, and next-generation cell therapies in regenerative medicine for ophthalmology (cornea, retina) and ischemia (stroke).
Looking forward to connecting with you there!

18/09/2024

TissueGUARD is pleased to announce that our CEO, Mikhail, will present at the Cornea and Eye Banking Forum 2024, which will be held on October 18, 2024, in Chicago, IL. The event is jointly sponsored by the Cornea Society and the Eye Bank Association of America (EBAA).
Mikhail will present "Universal Cannula Compartment Design for Both Endo-In and Endo-Out DMEK Implantation," highlighting an innovative solution to advance Descemet Membrane Endothelial Keratoplasty (DMEK) procedures. This universal design enhances flexibility and precision, providing significant benefits for both surgeons and patients involved in corneal transplantation.
TissueGUARD is committed to driving innovation in ophthalmic surgical devices, and we look forward to contributing to meaningful conversations at this esteemed forum.

21/08/2024

We are excited to share that we will be presenting at the ESCRS 2024 Congress in Barcelona! Our presentation, titled “Advancing Descemet Membrane Endothelial Keratoplasty: Efficient Tri-Folded Graft Delivery Protocol With A Hydrophobic Asymmetrical Injector,” has been accepted for a Free Paper presentation. This work represents a collaborative effort between TissueGUARD GmbH, Leibnitz Institut für Polymerforschung Dresden e.V., and our distinguished partner, Rocky Mountain Lions Eye Bank, USA.
We look forward to discussing our advancements in these innovative protocols and devices for endothelial keratoplasty and connecting with fellow professionals at the conference. If you're attending, we’d love to see you there! Let’s push the boundaries of ophthalmology together!

02/08/2024

Our CEO, Dr. Mikhail Tsurkan, recently visited the Lions Eye Bank of Wisconsin to demonstrate the TissueGUARD DMEK Injector SET. It was an honor to work with Dr. Tolulope Oyedun and Ivan Castaneda, and we were warmly welcomed by CEO Stacey M. Troha.
Our device is versatile and perfect for both naturally rolled DMEK and endo-in DMEK, which Dr. Tolulope Oyedun expertly prepared and tested. The team's positive feedback was encouraging and highlighted their dedication to advancing eye care. We look forward to continued collaboration to improve patient outcomes.
Thank you to the Lions Eye Bank of Wisconsin team for your hospitality and partnership. We are excited to start working with you.

21/07/2024

Our CEO Dr. Mikhail Tsurkan recently visited the Cincinnati Eye Bank to demonstrate the use of the TissueGUARD DMEK Injector SET in live settings. It was a pleasure working with Tina Mays, CEO of Cincinnati Eye Bank, and her dedicated team. Their enthusiasm and commitment to advancing eye care were evident throughout our visit.
The TissueGUARD DMEK Injector SET simplifies the DMEK procedure, and it was encouraging to see the positive response from the eye bank professionals.
Thank you to Tina Mays and the Cincinnati Eye Bank team for your warm welcome and partnership. We look forward to continued work together to improve patient outcomes.

05/06/2024

TissueGUARD is proud to announce that it has successfully received FDA registration and has listed its first medical device, the TissueGUARD DMEK Injector SET, for endothelial keratoplasty. We are immensely grateful for the Sächsische Aufbaubank - Förderbank – SAB grant (Förderrichtlinie Markteinführung innovativer Produkte, Verfahren oder Dienstleistungen Zuschuss EFRE) for commercializing innovative products, which partially funded this development. This is a significant milestone for our team and a testament to our commitment to advancing medical technology.
Thank you to everyone who has supported us on this journey. Follow us for more updates as we continue to present innovative medical products in the near future!

22/05/2024

TissueGUARD is happy to announce our participation in the Eye Bank Association of America meeting, which will be held June 5-8 in Kansas City, Missouri. We will showcase our new devices for cornea transplants!

At TissueGUARD, we focus on improving eye care with innovative solutions that enhance surgical outcomes and patient experiences. Our top-notch devices help surgeons perform DMEK procedures faster, easier, and safer.

Visit our booth at the EBAA meeting to see how TissueGUARD leads the way in cornea transplants. Let's connect and work together to achieve excellence in eye care!

29/02/2024

Exciting News from TissueGUARD! We're happy to announce our participation at the European Eye Bank Association meeting EEBA2024, where we're showcasing our innovative devices for cornea transplantation!
At TissueGUARD, we're dedicated to advancing ophthalmic care with innovative solutions that enhance surgical outcomes and patient experiences. Our cutting-edge devices represent the pinnacle of precision and reliability, empowering surgeons to perform DMEK procedures with utmost confidence and efficiency.
Visit our booth at the EEBA meeting to witness firsthand how TissueGUARD is shaping the future of cornea transplantation. Let's connect and collaborate towards excellence in eye care together!

31/10/2023

Our CEO, Mikhail V Tsurkan will be attending both the Corena Eye Banking Forum and the American Academy of Ophthalmology 2023 meetings in San Francisco from November 3rd to 6th. Reach out to us if you're interested in learning about our cutting-edge advancements in keratoplasty and retina transplantation devices and technologies.

Adresse

Dresden
01069

Telefon

+4935146581265

Webseite

https://tissueguard.de/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TissueGUARD erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.